Condition: Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2 · Sponsor: Louise Reagan
The proposed study will use a randomized clinical trial design with non-equivalent control group and longitudinal design to evaluate the feasibility, acceptability, and preliminary effects of the Diabetes LIVE JustICE application. The design will incorporate repeated measures at 0, 6, and 12 weeks. Outcome variables will include recruitment assessments, participation, engagement, user experience, and measures proximally related to behavior change - e.g., diabetes knowledge, diabetes-related distress, diabetes self-care, and social support and clinical outcomes -e.g., glycemic control. Focus group interviewing will be conducted to evaluate acceptability among intervention group participants.
This description comes directly from the study's public registry record.
Lousie Reagan, PhD · 860-486-0593 · louise.reagan@uconn.edu
Stephen Walsh, ScD · 860-486-0544 · stephen.walsh@uconn.edu
Always discuss trial participation with your own doctor first.
| University of Connecticut | Storrs, Connecticut, United States | Recruiting |
| University of Connecticut | Storrs Mansfield, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05286892